• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项针对痉挛患者的国际调查。

An international survey of patients living with spasticity.

作者信息

Barnes Michael, Kocer Serdar, Murie Fernandez Manuel, Balcaitiene Jovita, Fheodoroff Klemens

机构信息

a Christchurch Group , N Shields , Tyne and Wear , UK.

b Centre de Rééducation de l'Hôpital du Jura , Porrentruy , Switzerland.

出版信息

Disabil Rehabil. 2017 Jul;39(14):1428-1434. doi: 10.1080/09638288.2016.1198432. Epub 2016 Jul 6.

DOI:10.1080/09638288.2016.1198432
PMID:27385274
Abstract

PURPOSE

To better understand patient perspectives on the life impact of spasticity.

METHODS

Global Internet survey (April 2014-May 2015) of 281 people living with spasticity.

RESULTS

Respondents indicated that spasticity has a broad impact on their daily-life: 72% reported impact on quality of life, 44% reported loss of independence and 44% reported depression. Most respondents (64%) were cared for by family members, of whom half had stopped working or reduced their hours. Overall, 45% reported dissatisfaction with the information provided at diagnosis; main reasons were "not enough information" (67%) and "technical terminology" (36%). Respondents had high treatment expectations; 63% expected to be free of muscle spasm, 41% to take care of themselves and 36% to return to a normal routine. However, 33% of respondents had not discussed these expectations with their physician. The most common treatments were physiotherapy (75%), botulinum neurotoxin (BoNT, 73%) and oral spasmolytics (57%). Of those treated with BoNT, 47% waited >1 year from spasticity onset to treatment.

CONCLUSIONS

This survey emphasises the broad impact of spasticity and highlights unmet needs in the patient journey. Improvements with regards to communication and the therapeutic relationship would be especially welcomed by patients, and would help manage treatment expectations. Implications of Rehabilitation Spasticity has broad impact on the lives of patients and their families that extends beyond the direct physical disability. Patients with spasticity need to be well informed about their condition and treatments available and should be given the opportunity to discuss their expectations. Physicians need to be aware of the patient's individual needs and expectations in order to better help them achieve their therapeutic goals.

摘要

目的

更好地了解患者对痉挛对生活影响的看法。

方法

2014年4月至2015年5月对281名痉挛患者进行全球互联网调查。

结果

受访者表示痉挛对他们的日常生活有广泛影响:72%的人报告对生活质量有影响,44%的人报告失去独立性,44%的人报告有抑郁情绪。大多数受访者(64%)由家庭成员照顾,其中一半人停止工作或减少了工作时间。总体而言,45%的人报告对诊断时提供的信息不满意;主要原因是“信息不足”(67%)和“专业术语”(36%)。受访者对治疗期望很高;63%的人期望摆脱肌肉痉挛,41%的人期望能够自理,36%的人期望恢复正常生活。然而,33%的受访者尚未与医生讨论这些期望。最常见的治疗方法是物理治疗(75%)、肉毒杆菌神经毒素(BoNT,73%)和口服解痉药(57%)。在接受BoNT治疗的患者中,47%的人从痉挛发作到接受治疗等待了1年以上。

结论

本次调查强调了痉挛的广泛影响,并突出了患者就医过程中未得到满足的需求。患者尤其欢迎在沟通和治疗关系方面有所改善,这将有助于管理治疗期望。康复的意义痉挛对患者及其家庭生活的广泛影响超出了直接的身体残疾。痉挛患者需要充分了解自己的病情和可用治疗方法,并应有机会讨论他们的期望。医生需要了解患者的个人需求和期望,以便更好地帮助他们实现治疗目标。

相似文献

1
An international survey of patients living with spasticity.一项针对痉挛患者的国际调查。
Disabil Rehabil. 2017 Jul;39(14):1428-1434. doi: 10.1080/09638288.2016.1198432. Epub 2016 Jul 6.
2
Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity.COVID-19 大流行期间停止使用肉毒毒素 A 治疗:意大利一项针对伴有痉挛的脑卒中及创伤性脑损伤患者的调查。
Eur J Phys Rehabil Med. 2021 Jun;57(3):424-433. doi: 10.23736/S1973-9087.20.06478-3. Epub 2020 Dec 2.
3
Satisfaction with botulinum toxin treatment in post-stroke spasticity: results from two cross-sectional surveys (patients and physicians).中风后痉挛患者对肉毒杆菌毒素治疗的满意度:两项横断面调查(患者和医生)的结果
J Med Econ. 2014 Sep;17(9):618-25. doi: 10.3111/13696998.2014.925462. Epub 2014 Jun 12.
4
Perspective of an International Online Patient and Caregiver Community on the Burden of Spasticity and Impact of Botulinum Neurotoxin Therapy: Survey Study.国际在线患者和护理人员群体对痉挛负担和肉毒毒素治疗影响的观点:调查研究。
JMIR Public Health Surveill. 2020 Dec 7;6(4):e17928. doi: 10.2196/17928.
5
The use of botulinum toxin type A in the management of adult-onset focal spasticity: a survey of Australian allied health professionals.A型肉毒杆菌毒素在成人局灶性痉挛治疗中的应用:澳大利亚专职医疗人员的一项调查
Aust Occup Ther J. 2012 Aug;59(4):257-64. doi: 10.1111/j.1440-1630.2012.01027.x.
6
The Italian real-life post-stroke spasticity survey: unmet needs in the management of spasticity with botulinum toxin type A.意大利中风后痉挛的真实生活调查:A型肉毒杆菌毒素治疗痉挛的未满足需求
Funct Neurol. 2017 Apr/Jun;32(2):89-96. doi: 10.11138/fneur/2017.32.2.089.
7
More than a black box of rehabilitation: Characterizing therapy programmes following botulinum toxin injections for spasticity in adults with stroke.不仅仅是康复的黑箱:中风后成人痉挛性肉毒杆菌毒素注射治疗方案的特征分析
J Rehabil Med. 2016 Apr 28;48(5):426-34. doi: 10.2340/16501977-2085.
8
[Measuring outcome in spasticity rehabilitation].[痉挛性麻痹康复的疗效评估]
Wien Klin Wochenschr. 2001;113 Suppl 4:11-5.
9
Rehabilitation therapies after botulinum toxin-A injection to manage limb spasticity: a systematic review.肉毒毒素 A 注射治疗肢体痉挛后的康复治疗:系统评价。
Phys Ther. 2014 Nov;94(11):1569-81. doi: 10.2522/ptj.20130408. Epub 2014 Jul 24.
10
Goal Attainment Scaling in Individuals with Upper Limb Spasticity Post Stroke.中风后上肢痉挛个体的目标达成量表
Occup Ther Int. 2016 Dec;23(4):379-389. doi: 10.1002/oti.1440. Epub 2016 Oct 3.

引用本文的文献

1
What stroke survivors say about living with upper limb spasticity and how they manage it.中风幸存者如何看待上肢痉挛的生活状态以及他们是如何应对的。
Aust Occup Ther J. 2025 Oct;72(5):e70045. doi: 10.1111/1440-1630.70045.
2
Remote Monitoring for the Management of Spasticity: Challenges, Opportunities and Proposed Technological Solution.用于痉挛管理的远程监测:挑战、机遇与建议的技术解决方案
IEEE Open J Eng Med Biol. 2024 Dec 30;6:279-286. doi: 10.1109/OJEMB.2024.3523442. eCollection 2025.
3
A randomized, double-blind, placebo-controlled trial of DaxibotulinumtoxinA for Injection for the treatment of upper limb spasticity in adults after stroke or traumatic brain injury.
一项关于注射用达昔布妥昔单抗治疗中风或创伤性脑损伤后成人上肢痉挛的随机、双盲、安慰剂对照试验。
PM R. 2025 Feb;17(2):126-136. doi: 10.1002/pmrj.13258. Epub 2024 Oct 1.
4
Living With Spasticity During the COVID-19 Pandemic: A Qualitative Study of Patient, Carer and Physician Experiences.在 COVID-19 大流行期间应对痉挛:对患者、护理者和医生体验的定性研究。
Health Expect. 2024 Oct;27(5):e70032. doi: 10.1111/hex.70032.
5
Feasibility of Adjunct Therapy with a Robotic Hand Orthosis after Botulinum Toxin Injections in Persons with Spasticity: A Pilot Study.痉挛患者肉毒毒素注射后使用机器人手矫形器辅助治疗的可行性:一项初步研究。
Toxins (Basel). 2024 Aug 8;16(8):346. doi: 10.3390/toxins16080346.
6
The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis.A型肉毒毒素在痉挛中的作用:基于文献计量分析的研究趋势。
Toxins (Basel). 2024 Apr 9;16(4):184. doi: 10.3390/toxins16040184.
7
Botulinum toxin A injection for post-stroke upper limb spasticity and rehabilitation practices from centers across Asian countries.亚洲各国中心针对中风后上肢痉挛的A型肉毒杆菌毒素注射及康复实践。
Front Neurol. 2024 Apr 8;15:1335365. doi: 10.3389/fneur.2024.1335365. eCollection 2024.
8
Cost-effectiveness of abobotulinumtoxinA plus best supportive care compared with best supportive care alone for early treatment of adult lower limb spasticity following an acute event.阿柏西普毒素 A 联合最佳支持治疗对比单纯最佳支持治疗用于急性事件后成人下肢痉挛早期治疗的成本效益分析。
PLoS One. 2024 Feb 1;19(2):e0296340. doi: 10.1371/journal.pone.0296340. eCollection 2024.
9
Selecting Goals and Target Muscles for Botulinum Toxin A Injection Using the Goal Oriented Facilitated Approach to Spasticity Treatment (GO-FAST) Tool.使用痉挛治疗导向目标促进法(GO-FAST)工具选择肉毒毒素 A 注射的目标和靶肌肉。
Toxins (Basel). 2023 Nov 29;15(12):676. doi: 10.3390/toxins15120676.
10
An optimal model of long-term post-stroke care.卒中后长期护理的优化模型。
Front Neurol. 2023 Mar 23;14:1129516. doi: 10.3389/fneur.2023.1129516. eCollection 2023.